Triple Negative Breast Cancer with Andrew Seidman, MD and Joyce O'Shaughnessy, MD: Case 1

EP. 1: Joyce O'Shaughnessy, MD: Principle Third-Line Options for Patients With Metastatic TNBC

February 23rd 2016

EP. 2: Joyce O'Shaughnessy, MD: Efficacy Data Supporting the Use of Eribulin Mesylate

February 23rd 2016

EP. 3: Joyce O'Shaughnessy, MD: Different Mechanisms of Action in Eribulin

February 23rd 2016

EP. 4: Joyce O'Shaughnessy, MD: Main Indications for Dose Reduction With Eribulin

February 23rd 2016

EP. 5: Andrew Seidman, MD: Principle Third-Line Options for Patients With Metastatic TNBC

February 23rd 2016

EP. 6: Andrew Seidman, MD: Efficacy Data Supporting the Use of Eribulin Mesylate

February 23rd 2016

EP. 7: Andrew Seidman, MD: Different Mechanisms of Action in Eribulin

February 23rd 2016

EP. 8: Andrew Seidman, MD: Main Indications for Dose Reduction With Eribulin

February 23rd 2016